These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2865599)

  • 1. In vitro effect of foscarnet on expansion of T-cells from people with LAS and AIDS.
    Beldekas JC; Levy EM; Black P; Von Krogh G; Sandstrom E
    Lancet; 1985 Nov; 2(8464):1128-9. PubMed ID: 2865599
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of HTLV-III/LAV replication by foscarnet.
    Sarin PS; Taguchi Y; Sun D; Thornton A; Gallo RC; Oberg B
    Biochem Pharmacol; 1985 Nov; 34(22):4075-9. PubMed ID: 2415134
    [No Abstract]   [Full Text] [Related]  

  • 3. Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon.
    Hartshorn KL; Sandstrom EG; Neumeyer D; Paradis TJ; Chou TC; Schooley RT; Hirsch MS
    Antimicrob Agents Chemother; 1986 Jul; 30(1):189-91. PubMed ID: 3019235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome (AIDS).
    De Clercq E
    J Med Chem; 1986 Sep; 29(9):1561-9. PubMed ID: 2427720
    [No Abstract]   [Full Text] [Related]  

  • 5. Foscarnet.
    Lancet; 1985 Sep; 2(8456):648-9. PubMed ID: 2863637
    [No Abstract]   [Full Text] [Related]  

  • 6. Declining levels of HIV P24 antigen in serum during treatment with foscarnet.
    Bergdahl S; Sönnerborg A; Larsson A; Strannegard O
    Lancet; 1988 May; 1(8593):1052. PubMed ID: 2896890
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro recovery of resistant retrovirus isolates after exposure to phosphonoformate.
    Muratore O; Varnier OE; Raffanti SP; Schito GC
    Eur J Clin Microbiol; 1984 Oct; 3(5):447-9. PubMed ID: 6238823
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of sodium phosphonoformate on blood group antibody detection.
    Hunt AF; Jones MT; Howkins GJ
    Vox Sang; 1986; 51(3):231-2. PubMed ID: 2949433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet.
    Koshida R; Vrang L; Gilljam G; Harmenberg J; Oberg B; Wahren B
    Antimicrob Agents Chemother; 1989 May; 33(5):778-80. PubMed ID: 2526616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foscarnet infusion at home.
    Heley A
    Lancet; 1988 Dec; 2(8623):1311. PubMed ID: 2904032
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro inhibition of Herpesvirus sylvilagus by phosphonoacetic acid and phosphonoformate.
    Goodrich JM; Lee KW; Hinze HC
    Arch Virol; 1980; 66(3):261-4. PubMed ID: 6449917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of clinical spectrum of HTLV-III infection.
    Valle SL; Saxinger C; Ranki A; Antonen J; Suni J; Lähdevirta J; Krohn K
    Lancet; 1985 Feb; 1(8424):301-4. PubMed ID: 2857362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of foscarnet (phosphonoformate) on human immunodeficiency virus isolation, T-cell subsets and lymphocyte function in AIDS patients.
    Gaub J; Pedersen C; Poulsen AG; Mathiesen LR; Ulrich K; Lindhardt BO; Faber V; Gerstoft J; Hofmann B; Lernestedt JO
    AIDS; 1987 May; 1(1):27-33. PubMed ID: 2962590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiviral activity of phosphonoacetic acid, phosphonopropionic acid, and trisodium phosphonoformate hexahydrate against herpesvirus hominis type 1 and type 2 in vitro].
    Thiel KD; Wutzler P; Sprössig M; Bertram D
    Pharmazie; 1982 Aug; 37(8):608. PubMed ID: 6292963
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of sodium phosphonoformate on blood group antibody detection.
    Douglas R
    Vox Sang; 1987; 53(1):61. PubMed ID: 2958968
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS.
    Jacobson MA; Crowe S; Levy J; Aweeka F; Gambertoglio J; McManus N; Mills J
    J Infect Dis; 1988 Oct; 158(4):862-5. PubMed ID: 2844921
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe hypocalcaemia in AIDS patients treated with foscarnet and pentamidine.
    Youle MS; Clarbour J; Gazzard B; Chanas A
    Lancet; 1988 Jun; 1(8600):1455-6. PubMed ID: 2898602
    [No Abstract]   [Full Text] [Related]  

  • 18. [Importance of Foscarnet in the treatment of cytomegalovirus pneumopathy in a patient with acquired immunodeficiency syndrome].
    Brochard L; Salmeron S; Herve P; Petitpretz P; Boissonnas A; Simonneau G; Duroux P
    Presse Med; 1986 Nov; 15(40):2022-3. PubMed ID: 3025830
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of ribamidyl and phosphonoformic acid on the reproduction of the HTLV-III retrovirus in vitro].
    Nesterchuk SL; Gribencha SV; Barinskiĭ IF; Zhadanov VM
    Vopr Virusol; 1987; 32(3):364-6. PubMed ID: 2960081
    [No Abstract]   [Full Text] [Related]  

  • 20. Nitroblue tetrazolium (NBT) reduction by neutrophilic granulocytes in patients with HTLV-III infection.
    Sönnerborg A; Jarstrand C
    Scand J Infect Dis; 1986; 18(2):101-3. PubMed ID: 3010446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.